Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-06-01

Clinical Trial Update: Treatment of Functional Dyspepsia With Genuine Regional Rhizoma Atractylodis [NA]

View source ↗

Summary

A clinical trial update evaluating whether Genuine Regional Rhizoma Atractylodis improves functional dyspepsia compared with non-genuine regional rhizoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Genuine Regional Rhizoma Atractylodis
  • Non-genuine Regional Rhizoma Atractylodis

Snippet

Sponsor: China Academy of Chinese Medical Sciences | Conditions: Efficiency of Genuine Regional and Non-genuine Regional Rhizoma Atractylodis in Treating FD | NA | Status: UNKNOWN